BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35038704)

  • 1. MicroRNA-494-3p Exacerbates Renal Epithelial Cell Dysfunction by Targeting SOCS6 under High Glucose Treatment.
    Xue X; Liu M; Wang Y; Yang Y; Li Z; Shi R; Miao Y
    Kidney Blood Press Res; 2022; 47(4):247-255. PubMed ID: 35038704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-142-3p ameliorates high glucose-induced renal tubular epithelial cell injury by targeting BOD1.
    Zhao N; Luo Q; Lin R; Li Q; Ma P
    Clin Exp Nephrol; 2021 Nov; 25(11):1182-1192. PubMed ID: 34145485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0000064 promotes high glucose-induced renal tubular epithelial cells injury to facilitate diabetic nephropathy progression through miR-532-3p/ROCK1 axis.
    Wang H; Huang S; Hu T; Fei S; Zhang H
    BMC Endocr Disord; 2022 Mar; 22(1):67. PubMed ID: 35291991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA FLG-AS1 Mitigates Diabetic Retinopathy by Regulating Retinal Epithelial Cell Inflammation, Oxidative Stress, and Apoptosis via miR-380-3p/SOCS6 Axis.
    Luo R; Li L; Xiao F; Fu J
    Inflammation; 2022 Oct; 45(5):1936-1949. PubMed ID: 35461393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy.
    Yun J; Ren J; Liu Y; Dai L; Song L; Ma X; Luo S; Song Y
    Bioengineered; 2022 Jan; 13(1):634-644. PubMed ID: 34898373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy.
    Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H
    Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
    Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
    Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of miR-27a-3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress.
    Wu L; Wang Q; Guo F; Ma X; Wang J; Zhao Y; Yan Y; Qin G
    J Cell Physiol; 2021 Feb; 236(2):1454-1468. PubMed ID: 32691413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of circ_0003928 ameliorates high glucose-induced dysfunction of human tubular epithelial cells through the miR-506-3p/HDAC4 pathway in diabetic nephropathy.
    Liu Q; Cui Y; Ding N; Zhou C
    Eur J Med Res; 2022 Apr; 27(1):55. PubMed ID: 35392987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_WBSCR17 aggravates inflammatory responses and fibrosis by targeting miR-185-5p/SOX6 regulatory axis in high glucose-induced human kidney tubular cells.
    Li G; Qin Y; Qin S; Zhou X; Zhao W; Zhang D
    Life Sci; 2020 Oct; 259():118269. PubMed ID: 32798559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircTAOK1 regulates high glucose induced inflammation, oxidative stress, ECM accumulation, and apoptosis in diabetic nephropathy via targeting miR-142-3p/SOX6 axis.
    Liu SY; Wang H; Yang B; Hou B; Sun LS; Pang H; Wang HH; Fan YP
    Environ Toxicol; 2024 Apr; 39(4):2197-2207. PubMed ID: 38124441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO.
    Yang R; Xu X; Li H; Chen J; Xiang X; Dong Z; Zhang D
    Sci Rep; 2017 Feb; 7():43409. PubMed ID: 28240316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the miR-19b-mediated SOCS6-JAK2/STAT3 pathway by lncRNA MEG3 is involved in high glucose-induced apoptosis in hRMECs.
    Xiao F; Li L; Fu JS; Hu YX; Luo R
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32519748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA MALAT1 Promotes Renal Fibrosis in Diabetic Nephropathy by Targeting the miR-2355-3p/IL6ST Axis.
    Huang H; Zhang G; Ge Z
    Front Pharmacol; 2021; 12():647650. PubMed ID: 33995063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
    Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
    Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiRNA-133a-3p Attenuates Renal Tubular Epithelial Cell Injury via Targeting MALM1 and Suppressing the Notch Signaling Pathway in Diabetic Nephropathy.
    Li Y; Tan P; Liu Q; Liu M; Wang Y; Kong W; Sun H; Shao X
    Cell Biochem Biophys; 2024 Jun; ():. PubMed ID: 38878099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0000491 Promotes Apoptosis, Inflammation, Oxidative Stress, and Fibrosis in High Glucose-Induced Mesangial Cells by Regulating miR-455-3p/Hmgb1 Axis.
    Wang J; Yang S; Li W; Zhao M; Li K
    Nephron; 2022; 146(1):72-83. PubMed ID: 34474408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of the lncRNA
    Zhang B; Zhao C; Hou L; Wu Y
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1125-F1134. PubMed ID: 33135476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-32-5p knockdown inhibits epithelial to mesenchymal transition and renal fibrosis by targeting SMAD7 in diabetic nephropathy.
    Wang HJ; Liu H; Lin YH; Zhang SJ
    Hum Exp Toxicol; 2021 Apr; 40(4):587-595. PubMed ID: 32959695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy.
    Gao BH; Wu H; Wang X; Ji LL; Chen C
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.